https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Cohort study. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/ Tue, 01 Sep 2026 00:00:00 GMT The findings offer immunogenicity evidence relevant to booster vaccination strategy decisions during Omicron-era outbreaks, with particular relevance to settings where inactivated virus priming is used. COVID-19 SARS Vaccination Outbreak investigation Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/ Tue, 01 Sep 2026 00:00:00 GMT Findings support continued COVID-19 vaccine recommendations, demonstrating protection across the 2024-2025 season for adults including those with underlying medical conditions. COVID-19 Influenza Vaccination Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/ Tue, 01 Sep 2026 00:00:00 GMT The findings indicate that JN.1 vaccination provided limited additional protection against SARS-CoV-2 infection during a low-incidence period, with modest effectiveness observed in both age groups. The results contribute to understanding the real-world performance of updated COVID-19 vaccines against emerging subvariants. SARS COVID-19 Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75748-5-6d7271df/ https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75748-5-6d7271df/ Tue, 25 Aug 2026 00:00:00 GMT The demonstration of shared immune alterations across distinct critical illnesses suggests that similar targeted immunomodulation strategies may benefit multiple patient populations in intensive care settings. COVID-19 SARS Cohort study https://globalinfectiousdisease.com/research/articles/10-1093-trstmh-trag098-7ede4432/ https://globalinfectiousdisease.com/research/articles/10-1093-trstmh-trag098-7ede4432/ Tue, 25 Aug 2026 00:00:00 GMT The abstract presents fistula formation as a marker of greater disease complexity in hepatic cystic echinococcosis and identifies features associated with its occurrence. It describes possible relevance to monitoring and intervention in endemic settings, but this single-centre retrospective study does not establish population-level effects or surveillance trends. Echinococcosis Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-37432-jieph-d-26-00257-853d4094/ https://globalinfectiousdisease.com/research/articles/10-37432-jieph-d-26-00257-853d4094/ Mon, 24 Aug 2026 00:00:00 GMT The piece argues for integrated HIV/STI and mpox prevention and care, pre-exposure vaccination of at-risk people, continued investment in surveillance and data systems, and pre-approved emergency research protocols as part of outbreak preparedness, with a long-term aim beyond acute response. Monkeypox HIV infection Outbreak investigation Surveillance Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag542-e04c4d17/ https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag542-e04c4d17/ Fri, 21 Aug 2026 00:00:00 GMT Chronic Q fever cases are increasing in the United States, often without identifiable exposures. Diagnostic delays remain common and may contribute to morbidity in patients with cardiac or vascular conditions. Q fever Diagnostics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag533-2c8321c6/ https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag533-2c8321c6/ Thu, 20 Aug 2026 00:00:00 GMT The data underscore potential vulnerabilities in viral containment when standard prophylactic medication elements are removed from ongoing care plans. These observations may assist health authorities in refining monitoring protocols for patient populations transitioning between therapeutic strategies in areas where population-level immunization coverage remains incomplete. Hepatitis B Hepatitis D Treatment Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13588-w-e7170c47/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13588-w-e7170c47/ Wed, 19 Aug 2026 00:00:00 GMT Findings suggest nirmatrelvir/ritonavir may reduce risks of both acute severe outcomes and post-acute sequelae including long-COVID in high-risk outpatient populations, supporting continued use as a therapeutic option. COVID-19 SARS Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-3389-fped-2026-1807654-fef45b57/ https://globalinfectiousdisease.com/research/articles/10-3389-fped-2026-1807654-fef45b57/ Wed, 19 Aug 2026 00:00:00 GMT The findings quantify the heavy pediatric intensive-care burden of a vaccine-preventable disease and are framed in the abstract as supporting prevention priorities such as maternal vaccination, antenatal care, and safe delivery practices. Neonatal Tetanus Tetanus Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1818202-5ba8527e/ https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1818202-5ba8527e/ Tue, 18 Aug 2026 00:00:00 GMT Overcoming current diagnostic delays and incomplete resistance profiling could improve laboratory efficiency and support more informed therapeutic planning for a persistent global infectious disease burden. Tuberculosis Diagnostics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/ Mon, 17 Aug 2026 00:00:00 GMT The findings can inform decision-making, public health strategies, and policy development to protect vaccinated populations at elevated risk. The results support recommendations from Canada's National Advisory Committee on Immunisation for specific groups to remain current with COVID-19 vaccination to reduce severe outcomes. COVID-19 SARS Vaccination Health policy Cohort study https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0355725-723e2910/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0355725-723e2910/ Mon, 17 Aug 2026 00:00:00 GMT The findings provide article-level context on how multidrug-resistant Enterobacteriaceae characteristics and selected resistance patterns varied across the study's defined pandemic stages in an acute-care setting. The abstract presents these results as relevant to stage-adapted risk assessment and antimicrobial stewardship, but does not establish broader population-level effects. COVID-19 Surveillance Cohort study https://globalinfectiousdisease.com/research/articles/10-3390-diagnostics16162607-0f0d6ce6/ https://globalinfectiousdisease.com/research/articles/10-3390-diagnostics16162607-0f0d6ce6/ Mon, 17 Aug 2026 00:00:00 GMT The findings underscore the ongoing diagnostic utility of conventional inflammatory assays for initial case evaluation within standard clinical workflows. Brucellosis Diagnostics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014624-0abee3ac/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014624-0abee3ac/ Fri, 14 Aug 2026 00:00:00 GMT Regional incidence estimates and strain distributions offer foundational parameters for evaluating pediatric immunization strategies and directing sanitation resource allocation. Shigellosis Dysentery Surveillance Transmission dynamics Vaccination Antimicrobial resistance Diagnostics Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109050-e68257a0/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109050-e68257a0/ Sat, 01 Aug 2026 00:00:00 GMT The substantial proportion of patients experiencing chronic symptoms with functional impact suggests a need for early risk stratification and integration of long-term care protocols into arboviral disease management systems. Chikungunya Dengue Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109089-f7d2319d/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109089-f7d2319d/ Sat, 01 Aug 2026 00:00:00 GMT The authors highlight a high prevalence and rapid onset of influenza-associated pulmonary aspergillosis in critically ill patients and call for protocolized screening and timely diagnostics. COVID-19 Influenza Diagnostics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2026-101407-4e147d53/ https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2026-101407-4e147d53/ Sat, 01 Aug 2026 00:00:00 GMT Exclusive reliance on clinical symptoms for identifying infected persons may overlook a major driver of ongoing dissemination, indicating that systematic screening protocols are essential in congregate environments. Tuberculosis Genomic epidemiology Transmission dynamics Surveillance Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2026-101490-acbdd747/ https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2026-101490-acbdd747/ Sat, 01 Aug 2026 00:00:00 GMT The authors identify maternal vaccination and timely childhood immunisation as potentially relevant to reducing the early-life period of limited influenza B antibody protection. This is an interpretation reported by the study and does not establish intervention effectiveness. Influenza Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128821-769efdf1/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128821-769efdf1/ Sat, 01 Aug 2026 00:00:00 GMT Contemporaneous incidence estimates for 30 safety outcomes across five organ systems can inform benefit-risk framing for new and existing respiratory vaccines during the COVID-19 endemic era and highlight the need to account for age and sex when interpreting expected rates. COVID-19 Influenza SARS Vaccination Surveillance Vaccine safety Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128838-7867d6e4/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128838-7867d6e4/ Sat, 01 Aug 2026 00:00:00 GMT The abstract identifies increased use of the two-dose schedule, evaluation of the vaccination interval, and possible inclusion of varicella vaccine in national programs as measures that could reduce breakthrough infections. These implications are the authors' conclusions and are not independently validated by the supplied evidence. Varicella Vaccination Surveillance Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128847-1a3be2a6/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128847-1a3be2a6/ Sat, 01 Aug 2026 00:00:00 GMT The findings underscore how parental immunization perspectives shape broader pediatric preventive care patterns within American households. COVID-19 SARS Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128859-781cd1dc/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128859-781cd1dc/ Sat, 01 Aug 2026 00:00:00 GMT The findings support a practical vaccination strategy to reduce HZ and its complications in liver transplant recipients, a population at elevated immunocompromise-related risk. Zoster Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128868-6b4dc9ed/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128868-6b4dc9ed/ Sat, 01 Aug 2026 00:00:00 GMT The findings provide context on observed hospitalization and mortality patterns among laboratory-confirmed Omicron cases according to documented prior immunity profiles in this Iranian registry population. The analysis does not estimate protection against acquiring infection. SARS COVID-19 Vaccination Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128912-61c4c107/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128912-61c4c107/ Sat, 01 Aug 2026 00:00:00 GMT Sustaining elevated protection levels in this clinical subgroup requires targeted communication strategies that address safety perceptions and counteract inaccurate health information. COVID-19 AIDS Vaccination Vaccine safety Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00114-3-04b32a83/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00114-3-04b32a83/ Sat, 01 Aug 2026 00:00:00 GMT The MTB-HR assay did not meet WHO target product profile criteria for screening or prognostic use, but its positive predictive value exceeded that of currently used tests. The authors suggest the assay may still have a role in tuberculosis screening and prevention strategies for household contacts, a priority population where existing tests perform poorly. Tuberculosis Diagnostics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108664-4291962d/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-108664-4291962d/ Wed, 01 Jul 2026 00:00:00 GMT The findings highlight arboviruses, particularly chikungunya, dengue, and the emerging Oropouche virus, as leading causes of acute neurological syndromes in Brazil. The authors emphasize that integrating multiplex viral panels with arboviral assays is essential for improved diagnosis, and that strengthened surveillance and molecular diagnostics are critical in regions with ongoing arboviral transmission. Dengue Chikungunya Surveillance Diagnostics Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-ttbdis-2026-102673-9fdde805/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ttbdis-2026-102673-9fdde805/ Thu, 18 Jun 2026 00:00:00 GMT Findings suggest that an acute-phase glial biomarker in CSF may help identify tick-borne encephalitis patients at risk of persistent cognitive deficits, which is relevant given the frequency of long-term cognitive sequelae reported in this cohort. Tick-borne encephalitis Cohort study https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13800-x-ccbbbebb/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13800-x-ccbbbebb/ Tue, 16 Jun 2026 00:00:00 GMT The findings identify two vulnerable populations requiring enhanced intervention: older patients and those with TB/HIV co-infection. The authors recommend strengthening TB/HIV service integration and providing targeted clinical management and adherence support for older patients to improve treatment outcomes. Tuberculosis Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13779-5-8a4a8d1e/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13779-5-8a4a8d1e/ Mon, 15 Jun 2026 00:00:00 GMT Findings suggest a 'suppression-rebound' effect of NPIs on childhood Chlamydia pneumoniae pneumonia, with a shift toward school-aged children and implications for targeted school-based prevention and optimized antibiotic treatment. Chlamydial pneumonia Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/ Sat, 13 Jun 2026 00:00:00 GMT The findings address vaccine-preventable PCC burden in a high-risk age group during the first post-pandemic season and are positioned as input for vaccination policy, communication, and clinical decision-making. COVID-19 SARS Vaccination Vaccine effectiveness Health policy Cohort study https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13760-2-8d5bcb5e/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13760-2-8d5bcb5e/ Fri, 12 Jun 2026 00:00:00 GMT The authors propose that integrating routine blood tests into initial assessments could streamline diagnostic pathways for suspected complicated infections. Brucellosis Treatment Diagnostics One Health Cohort study https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13659-y-7e9eb5db/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13659-y-7e9eb5db/ Wed, 10 Jun 2026 00:00:00 GMT The findings highlight the need for early identification and targeted interventions for high-risk COVID-19 patients, particularly elderly individuals and those with cancer or neurological symptoms. The temporal analysis across six waves provides evidence to inform preparedness and response strategies in similar middle-income country settings. COVID-19 SARS Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128630-6d3ff677/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128630-6d3ff677/ Mon, 01 Jun 2026 00:00:00 GMT The findings provide Canadian adult vaccine-safety evidence on short-term health events following two-dose mRNA vaccination and include comparison with an unvaccinated group. The abstract describes symptom frequency and healthcare-utilization outcomes but does not establish longer-term effects or causality. COVID-19 SARS Vaccination Vaccine safety Surveillance Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2025-101293-2e1d7dc7/ https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2025-101293-2e1d7dc7/ Sun, 01 Mar 2026 00:00:00 GMT Authors emphasize the necessity of prioritizing systematic monitoring for resistance to maintain effective treatment protocols. Elevated resistance levels in certain subgroups underscore the importance of updated diagnostic and therapeutic approaches. Tuberculosis Surveillance Antimicrobial resistance Diagnostics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00545-6-9f0c6065/ Sun, 01 Feb 2026 00:00:00 GMT The observed differences in immune durability between natural infection and vaccination highlight potential considerations for maintaining population-level protection against circulating orthopoxviruses. Smallpox Monkeypox Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1712115-7b1cb92c/ https://globalinfectiousdisease.com/research/articles/10-3389-fcimb-2026-1712115-7b1cb92c/ Tue, 27 Jan 2026 00:00:00 GMT These observational data highlight how metabolic comorbidities intersect with viral hepatitis trajectories, providing contextual information for epidemiological tracking and early risk stratification frameworks. Hepatitis B Hepatitis D Acute hepatitis B Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2025-08-019-736f724d/ https://globalinfectiousdisease.com/research/articles/10-1016-j-cmi-2025-08-019-736f724d/ Thu, 01 Jan 2026 00:00:00 GMT The analysis highlights structural deficiencies in current observational research infrastructure that could delay coordinated responses during emerging infectious disease events. Standardizing data collection and maintaining continuous monitoring networks are presented as essential steps for timely public health interventions. Monkeypox Outbreak investigation Vaccination Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-099827-90b6b044/ https://globalinfectiousdisease.com/research/articles/10-1136-bmjopen-2025-099827-90b6b044/ Thu, 17 Jul 2025 00:00:00 GMT Documented discrepancies in clinical workflows and patient outcomes underscore the necessity for harmonized regional guidelines tailored to specific epidemiological contexts. Rheumatic fever Diagnostics Cohort study https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013254-6d493bbd/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0013254-6d493bbd/ Wed, 16 Jul 2025 00:00:00 GMT The findings indicate that most CHIKV infections in children are symptomatic, a small but notable proportion fail to seroconvert after acute infection, and chronic disease can occur in the pediatric population. These patterns support the need for sustained surveillance and age-appropriate interventions for chikungunya in children and adolescents. Chikungunya Dengue Surveillance Vaccination Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/ Tue, 01 Jul 2025 00:00:00 GMT The article provides Germany-specific observational evidence on MVA-BN safety and estimated effectiveness in the population studied during the 2022-2023 mpox period. Its findings may inform editorial context about vaccination evidence, including the reported difference in estimated effectiveness by HIV status, but they do not establish causality or confirm a current surveillance pattern. Smallpox Monkeypox Vaccination Vaccine effectiveness Outbreak investigation Transmission dynamics Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2024-106399-1ce73fa4/ https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2024-106399-1ce73fa4/ Sat, 01 Feb 2025 00:00:00 GMT Early detection of treatment failure is critical for improving drug-resistant tuberculosis management. MBLA demonstrated superior early identification of successful culture conversion compared to existing tests and may serve as a useful biomarker for evaluating novel anti-tuberculosis agents in early-phase clinical trials. Tuberculosis Antimicrobial resistance Diagnostics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004452-283a778b/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004452-283a778b/ Mon, 16 Sep 2024 00:00:00 GMT The paper presents TB screening as a possible point to find and address other health problems in affected households. It frames integrated approaches as a way to identify people at higher risk and connect them with preventive or treatment services. Tuberculosis AIDS Climate and environment Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2023-11-010-fa8cc9af/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2023-11-010-fa8cc9af/ Mon, 01 Jan 2024 00:00:00 GMT The findings support the value of whole genome sequencing for identifying clusters and resistance mutations in low-burden settings, which can inform contact tracing, surveillance, and treatment strategies for drug-resistant TB. Tuberculosis Genomic epidemiology Transmission dynamics Antimicrobial resistance Outbreak investigation Surveillance Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00374-2-e8a8c71c/ https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00374-2-e8a8c71c/ Fri, 01 Dec 2023 00:00:00 GMT Second mRNA booster doses provided additional protection against severe COVID-19 in adults aged 60 years and older beyond that offered by the first booster. The bivalent vaccine targeting the original strain plus BA.4-5 offered greater protection than monovalent boosters and sustained effectiveness up to four months, informing booster recommendations for older populations during omicron BA.5 circulation. COVID-19 SARS Surveillance Vaccination Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-23-00172-6-4080c24a/ https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-23-00172-6-4080c24a/ Fri, 01 Dec 2023 00:00:00 GMT The findings demonstrate substantial bedaquiline-resistance gain in programmatically treated patients and provide evidence of bedaquiline-resistant strain transmission. The authors emphasize that routine drug susceptibility testing should urgently accompany scale-up of novel tuberculosis drugs, though rapid testing remains challenging due to genetic variant diversity. Tuberculosis Antimicrobial resistance Transmission dynamics Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taad051-ca675e4f/ https://globalinfectiousdisease.com/research/articles/10-1093-jtm-taad051-ca675e4f/ Wed, 19 Apr 2023 00:00:00 GMT Acute gastroenteritis remains a prevalent disease among international travelers. Although norovirus accounted for a small proportion of cases, infections resulted in notably high clinical severity and substantial disruption to travel plans. The findings may inform targeted vaccine development strategies and guide the design of future norovirus epidemiology studies in traveler populations. Gastroenteritis Travel medicine Climate and environment Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciad059-c5c17137/ https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciad059-c5c17137/ Wed, 08 Feb 2023 00:00:00 GMT High infection rates and prolonged shedding in infants and children, particularly among malnourished children, support that household transmission is an important exposure route for young infants. Treatment of nondiarrheal infection may be essential for interrupting person-to-person transmission within homes and preventing cryptosporidiosis in infants. Cryptosporidiosis COVID-19 SARS Transmission dynamics Vaccination Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2021-11-094-d3bf0be6/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2021-11-094-d3bf0be6/ Sat, 01 Jan 2022 00:00:00 GMT The abstract provides evidence about vaccine perceptions and uptake patterns in an essential-worker cohort, including differences by occupation, prior infection, and initial vaccine intention. It also reports changes in vaccine-related responses between survey administrations, which may be relevant to research on vaccine acceptance in similar populations. SARS COVID-19 Vaccination Vaccine effectiveness Outbreak investigation Vaccine safety Cohort study https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciab745-fafd315d/ https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciab745-fafd315d/ Tue, 31 Aug 2021 00:00:00 GMT The authors indicate that combining genomic and spatial information may help identify areas with higher incidence and inform targeted environmental surveillance and typhoid control strategies. These implications are presented as applications of the study findings, not as evidence that such interventions were evaluated. Typhoid fever Transmission dynamics Climate and environment Surveillance Cohort study